• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

341株非发酵革兰阴性菌对七种β-内酰胺类抗生素的敏感性

Sensitivity of 341 non-fermentative gram-negative bacteria to seven beta-lactam antibiotics.

作者信息

Appelbaum P C, Tamim J, Stavitz J, Aber R C, Pankuch G A

出版信息

Eur J Clin Microbiol. 1982 Jun;1(3):159-65. doi: 10.1007/BF02019617.

DOI:10.1007/BF02019617
PMID:7173181
Abstract

Susceptibility of 341 isolates of non-fermentative gram-negative bacteria to carbenicillin, piperacillin, cefoperazone, moxalactam, cefotaxime, ceftizoxime, and N-formimidoyl thienamycin was determined by the agar dilution and disc diffusion methods. Piperacillin was the most active agent against Pseudomonas aeruginosa, thienamycin the most active against Pseudomonas fluorescens and Pseudomonas putida, and moxalactam the most active against Pseudomonas maltophilia. Piperacillin and thienamycin were the most active agents against the other Pseudomonas species studied. Thienamycin proved to have excellent activity against Acinetobacter calcoaceticus--90% of strains were inhibited by less than or equal to 1 microgram/ml. The two most active drugs against Alcaligenes species were piperacillin and thienamycin, both of which inhibited 90% of isolates at a concentration of 2 micrograms/ml. All drugs were active against Moraxella species. The broad sensitivity spectrum of piperacillin, thienamycin, and the third-generation cephalosporins against non-fermentative gram-negative bacteria indicates their potential use in infections caused by these organisms.

摘要

采用琼脂稀释法和纸片扩散法测定了341株非发酵革兰氏阴性菌对羧苄青霉素、哌拉西林、头孢哌酮、拉氧头孢、头孢噻肟、头孢唑肟和N-甲酰亚胺硫霉素的敏感性。哌拉西林是对铜绿假单胞菌活性最强的药物,硫霉素是对荧光假单胞菌和恶臭假单胞菌活性最强的药物,拉氧头孢是对嗜麦芽窄食单胞菌活性最强的药物。哌拉西林和硫霉素是对所研究的其他假单胞菌属活性最强的药物。硫霉素对乙酸钙不动杆菌具有优异的活性——90%的菌株在小于或等于1微克/毫升的浓度下被抑制。对产碱杆菌属活性最强的两种药物是哌拉西林和硫霉素,二者在2微克/毫升的浓度下均能抑制90%的分离株。所有药物对莫拉菌属均有活性。哌拉西林、硫霉素和第三代头孢菌素对非发酵革兰氏阴性菌的广泛敏感谱表明它们在由这些微生物引起的感染中具有潜在用途。

相似文献

1
Sensitivity of 341 non-fermentative gram-negative bacteria to seven beta-lactam antibiotics.341株非发酵革兰阴性菌对七种β-内酰胺类抗生素的敏感性
Eur J Clin Microbiol. 1982 Jun;1(3):159-65. doi: 10.1007/BF02019617.
2
Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.接种量对头孢哌酮、头孢噻肟、拉氧头孢、哌拉西林及N-甲酰亚胺硫霉素(MK0787)抗铜绿假单胞菌活性的影响。
Antimicrob Agents Chemother. 1980 Dec;18(6):893-6. doi: 10.1128/AAC.18.6.893.
3
Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.与头孢噻肟、拉氧头孢、头孢哌酮、哌拉西林-庆大霉素相比,N-甲脒硫霉素的抗菌活性。
Infection. 1982 Jan;10(1):45-9. doi: 10.1007/BF01640838.
4
In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime.与头孢噻肟、拉氧头孢和头孢他啶相比,N-甲酰亚胺硫霉素的体外活性。
Antimicrob Agents Chemother. 1981 Mar;19(3):402-6. doi: 10.1128/AAC.19.3.402.
5
[Comparative in vitro activity of 6 recent beta-lactams against hospital strains of Acinetobacter calcoaceticus: role of the monobactam SQ 26,776].6种新型β-内酰胺类药物对医院分离的醋酸钙不动杆菌菌株的体外比较活性:单环β-内酰胺类药物SQ 26,776的作用
Pathol Biol (Paris). 1983 May;31(5):392-5.
6
A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives.N-甲酰亚胺基硫霉素(MK0787)与其他近期研发的β-内酰胺衍生物抗菌活性的比较。
Antimicrob Agents Chemother. 1982 Aug;22(2):302-7. doi: 10.1128/AAC.22.2.302.
7
In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.与羟羧氧酰胺菌素和头孢噻肟相比,N-甲脒硫霉素对庆大霉素耐药革兰氏阴性菌的体外活性
Eur J Clin Microbiol. 1982 Feb;1(1):49-51. doi: 10.1007/BF02014140.
8
Effects of inducible beta-lactamase and antimicrobial resistance upon the activity of newer beta-lactam antibiotics against Pseudomonas aeruginosa.可诱导β-内酰胺酶及抗菌药物耐药性对新型β-内酰胺类抗生素抗铜绿假单胞菌活性的影响。
J Antibiot (Tokyo). 1981 Oct;34(10):1334-40. doi: 10.7164/antibiotics.34.1334.
9
Pseudomonas aeruginosa and Acinetobacter calcoaceticus: in vitro susceptibility of 150 clinical isolates to five beta-lactam antibiotics and tobramycin.
Chemotherapy. 1983;29(5):332-6. doi: 10.1159/000238216.
10
Comparative activities of 13 beta-lactam antibiotics.13种β-内酰胺类抗生素的比较活性
Antimicrob Agents Chemother. 1982 Jun;21(6):925-34. doi: 10.1128/AAC.21.6.925.

引用本文的文献

1
Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods.曲伐沙星单独及与其他药物联合应用对革兰阴性非发酵菌的比较活性
Antimicrob Agents Chemother. 1997 Jul;41(7):1475-81. doi: 10.1128/AAC.41.7.1475.
2
Activities of beta-lactams against Acinetobacter genospecies as determined by agar dilution and E-test MIC methods.通过琼脂稀释法和E-test MIC法测定β-内酰胺类药物对不动杆菌属菌种的活性。
Antimicrob Agents Chemother. 1997 Apr;41(4):767-70. doi: 10.1128/AAC.41.4.767.
3
Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem.

本文引用的文献

1
Four methods for identification of gram-negative nonfermenting rods: organisms more commonly encountered in clinical specimens.革兰阴性非发酵菌的四种鉴定方法:临床标本中更常见的微生物
J Clin Microbiol. 1980 Aug;12(2):271-8. doi: 10.1128/jcm.12.2.271-278.1980.
2
In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents.除铜绿假单胞菌外的非发酵革兰氏阴性杆菌对32种抗菌药物的体外敏感性
Rev Infect Dis. 1980 Nov-Dec;2(6):841-53. doi: 10.1093/clinids/2.6.841.
3
Comparison of in vitro activities of eight beta-lactamase-stable cephalosporins against beta-lactamase-producing gram-negative bacilli.
非铜绿假单胞菌革兰氏阴性非发酵菌对环丙沙星、氧氟沙星、左氧氟沙星、D-氧氟沙星、司帕沙星、头孢他啶、哌拉西林、哌拉西林-他唑巴坦、甲氧苄啶-磺胺甲恶唑和亚胺培南的敏感性。
Antimicrob Agents Chemother. 1996 Mar;40(3):772-5. doi: 10.1128/AAC.40.3.772.
4
A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy.嗜麦芽窄食单胞菌对抗菌药物敏感性的变化模式:对治疗的启示
Antimicrob Agents Chemother. 1994 Mar;38(3):624-7. doi: 10.1128/AAC.38.3.624.
5
Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.拉氧头孢。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1983 Oct;26(4):279-333. doi: 10.2165/00003495-198326040-00001.
6
Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.头孢噻肟:抗菌活性、药理特性及治疗用途综述
Drugs. 1983 Mar;25(3):223-89. doi: 10.2165/00003495-198325030-00001.
7
High performance liquid chromatographic determination of moxalactam in human plasma and cerebrospinal fluid.高效液相色谱法测定人血浆和脑脊液中拉氧头孢的含量。
Eur J Clin Pharmacol. 1985;29(2):225-9. doi: 10.1007/BF00547427.
8
Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.头孢唑肟:抗菌活性、药代动力学特性及治疗用途综述
Drugs. 1985 Apr;29(4):281-329. doi: 10.2165/00003495-198529040-00001.
9
[Calculated initial chemotherapy in mechanically-ventilated postoperative patients with peritonitis, sepsis and pneumonia].[机械通气的术后腹膜炎、脓毒症和肺炎患者的初始化疗方案计算]
Infection. 1986;14 Suppl 2:S164-70. doi: 10.1007/BF01647503.
10
Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.亚胺培南/西司他丁。对其抗菌活性、药代动力学特性及治疗效果的综述。
Drugs. 1987 Mar;33(3):183-241. doi: 10.2165/00003495-198733030-00001.
八种β-内酰胺酶稳定型头孢菌素对产β-内酰胺酶革兰氏阴性杆菌的体外活性比较
Antimicrob Agents Chemother. 1981 Mar;19(3):407-13. doi: 10.1128/AAC.19.3.407.
4
Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin.头孢唑肟(一种对β-内酰胺酶稳定的头孢菌素)的抗菌活性
Antimicrob Agents Chemother. 1980 Apr;17(4):583-90. doi: 10.1128/AAC.17.4.583.
5
In-vitro antibacterial activity of cefoperazone, a piperazine cephalosporin.哌嗪头孢菌素头孢哌酮的体外抗菌活性
J Antimicrob Chemother. 1981 Aug;8(2):107-13. doi: 10.1093/jac/8.2.107.
6
Tentative interpretive standards for disk susceptibility tests with moxalactam (LY127935).莫西拉酸(LY127935)纸片药敏试验的暂行解释标准。
Antimicrob Agents Chemother. 1980 Nov;18(5):716-21. doi: 10.1128/AAC.18.5.716.
7
In vitro activity of cefoperazone against nonfermenters and Aeromonas hydrophila.头孢哌酮对非发酵菌和嗜水气单胞菌的体外活性。
Antimicrob Agents Chemother. 1980 Sep;18(3):483-6. doi: 10.1128/AAC.18.3.483.
8
Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.莫西拉酸(LY127935),一种新型半合成1-氧杂-β-内酰胺抗生素,具有显著的抗菌活性:与头孢孟多和妥布霉素的体外比较。
Antimicrob Agents Chemother. 1980 Apr;17(4):750-6. doi: 10.1128/AAC.17.4.750.
9
Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin.头孢哌酮(T - 1551),一种新型半合成头孢菌素:与头孢噻吩和庆大霉素的比较。
Antimicrob Agents Chemother. 1980 Apr;17(4):743-9. doi: 10.1128/AAC.17.4.743.
10
In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime.与头孢噻肟、拉氧头孢和头孢他啶相比,N-甲酰亚胺硫霉素的体外活性。
Antimicrob Agents Chemother. 1981 Mar;19(3):402-6. doi: 10.1128/AAC.19.3.402.